Filing Flows › Acadia Healthcare Company (ACHC) › Guidance & outlook
Acadia Healthcare Company (ACHC) guidance and outlook
Acadia Healthcare Company (ACHC) raised some and lowered other parts of its guidance on Nov 4, 2026: EBITDA $13.4M for FY2026; Revenue $3.4B–$3.5B for FY2026; EBITDA $615M–$625M for FY2026; EPS $1.70–$1.80 for FY2026. Acadia Healthcare Company's 10-Q filed Nov 4, 2026 makes 7 forward-looking statements, 1 of them new and 1 no longer said since the filing before.
Guidance and outlook
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| EBITDA | FY2026 | $13.4M | raised |
| Revenue | FY2026 | $3.4B–$3.5B | raised |
| EBITDA | FY2026 | $615M–$625M | raised |
| EPS | FY2026 | $1.70–$1.80 | raised |
| Operating cash flow | FY2026 | $375M–$400M | raised |
| Capital expenditures | FY2026 | $210M–$230M | lowered |
From the earnings release filed Nov 4, 2026 (8-K on EDGAR).
Forward-looking statements, 10-Q filed Nov 4, 2026
- the impact of the restructuring, consolidation, and elimination of federal agencies that regulate the healthcare industry, which could result in changes to federal agency reviews and enforcement activities, priorities, and guidance, and has the potential to cause delays in obtaining necessary or desired reviews and approvals for our facilities;
- Management expects to take advantage of several strategies that are more accessible as a result of our increased size and geographic scale, including continuing a national marketing strategy to attract new patients and referral sources, increasing our volume of out-of-state referrals, providing a broader range of services to new and existing patients and clients and selectively pursuing opportunities to expand…
- We are unable to predict whether or how future legislation, rulemaking, or judicial action will impact implementation of the OBBBA.
- new · However, the scope and application of these exemptions will depend on federal implementing guidance and state implementation, and we may not realize their anticipated benefit.
- Other operating expenses for the nine months ended September 30, 2026 includes an unfavorable adjustment of $28.6 million to our estimated liability for self-insured professional and general liability claims relating to the settlement or expected settlement of certain prior year claims.
- updated · At September 30, 2026, we had $710.1 million of availability under the Revolving Facility and had standby letters of credit outstanding of $15.9 million related to security for multiple development projects.
- The projected interest payments reflect the interest rates in place on our variable-rate debt at September 30, 2026.
Acadia Healthcare Company's latest quarter
Acadia Healthcare Company, Q3 2026: revenue $895M (+5% year over year), operating margin 6.3%, net earnings $34.5M, operating cash flow $97.9M. The chart follows the revenue to costs, profit and cash.
Questions
Did Acadia Healthcare Company raise or lower its guidance?
Acadia Healthcare Company (ACHC) raised some and lowered other parts of its guidance on Nov 4, 2026: EBITDA $13.4M for FY2026; Revenue $3.4B–$3.5B for FY2026; EBITDA $615M–$625M for FY2026; EPS $1.70–$1.80 for FY2026.
What does Acadia Healthcare Company expect?
However, the scope and application of these exemptions will depend on federal implementing guidance and state implementation, and we may not realize their anticipated benefit. At September 30, 2026, we had $710.1 million of availability under the Revolving Facility and had standby letters of credit outstanding of $15.9 million related to security for multiple development projects.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.